Capital Analysts LLC’s Charles River Laboratories CRL Stock Holding History

Capital Analysts LLC’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$1K	–	1549
2026 Q1	$1K	Buy	+4	New	+$742	﹤0.01%	1490
2025 Q3	–	Sell	-6	Closed	-$1K	–	1433
2025 Q2	$1K	Buy	+6	New	+$800	﹤0.01%	1339
2025 Q1	–	Sell	-6	Closed	-$1K	–	1377
2024 Q4	$1K	Buy	+6	New	+$1.16K	﹤0.01%	1248
2021 Q2	–	Sell	-5	Closed	-$1K	–	967
2021 Q1	$1K	Buy	+5	New	+$1.39K	﹤0.01%	1003

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Capital Analysts LLC's CRL Position: Q2 2026 in Review

Capital Analysts LLC sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 4 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in CRL in Q1 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2026. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Capital Analysts LLC reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
Capital Analysts LLC sold 4 Charles River Laboratories shares in Q2 2026, an estimated $1K.
Capital Analysts LLC first reported a position in Charles River Laboratories in Q1 2021 and held it in 4 quarters.
Capital Analysts LLC's Charles River Laboratories position peaked at $1K in Q1 2026.
563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.